Chief Medical Officer Cecília Müller said Hungary’s National Public Health Authority (NNK) is examining China’s Sinopharm vaccine, 550,000 doses of which were delivered to the country on Tuesday.
According to MTI, the chief medical officer said experts have also received the vaccine’s documentation and will soon issue guidelines on its use and information for patients. In Hungary, 348,927 people have been inoculated so far and 124,824 have also received their second jab. Vaccine recipients have so far reported only mild side effects from the jabs, she said.
The CMO added that “the epidemic is not loosening its grip”, with the number of active infections at 77,250 in the past 24 hours. Traces of the virus in waste water, a marker of the spread of the epidemic, has grown in several cities, including Szeged, Székesfehérvár, Szolnok and Zalaegerszeg.
Müller said health experts were also studying the virus’s various mutations. Laboratory tests have so far identified 193 cases of the UK variant of the virus in Hungary, she said, adding that mutations originating from South Africa and Brazil have not yet been detected. Though the UK variant does not appear to produce more severe symptoms than the most common form of the virus, it is able to spread faster, she noted.
In response to a question, the CMO said that if someone contracts the virus between receiving their two shots, the second jab can only be administered after the individual has recovered. She attributed the low number of flu cases registered this year to the public’s adherence to mask wearing and social distancing rules.
Photo credit: Origo